Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA055261-08
Application #
6300402
Study Section
Project Start
2000-02-16
Project End
2002-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
8
Fiscal Year
2000
Total Cost
$141,510
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Liu, Yanhong; Shete, Sanjay; Hosking, Fay et al. (2010) Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20:239-44
Puduvalli, V K; Sampath, D; Bruner, J M et al. (2005) TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation. Apoptosis 10:233-43
Levin, Victor A; Hess, Kenneth R; Choucair, Ali et al. (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981-90
Puduvalli, Vinay K; Hashmi, Masood; McAllister, Leslie D et al. (2003) Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 65:259-66
Wrensch, Margaret; Minn, Yuriko; Chew, Terri et al. (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-99
Berrak, Su Gulsun; Ozek, Memet M; Canpolat, Cengiz et al. (2002) Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors. Childs Nerv Syst 18:485-91
de Andrade, M; Barnholtz, J S; Amos, C I et al. (2001) Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 20:258-70
Davies, M A; Koul, D; Dhesi, H et al. (1999) Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59:2551-6
Sano, T; Lin, H; Chen, X et al. (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59:1820-4
Levin, V A (1999) Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading. Neuro Oncol 1:69-80

Showing the most recent 10 out of 36 publications